#cannabisaficionado

Culture

PlantEd Collective: 5 Women Changing Europe’s Cannabis Conversation

Published

on

PlantEd Collective
Abby Hughes, Carly Barton, Victora Logan, Liz Dyer and Jade Proudman. PHOTO | PlantEd Collective
Advertisement Back2Grow Advertisement

Misinformation is one of the greatest issues faced when talking about medical cannabis and cannabinoids. There is a lot of wrong information out there that can be confusing and misleading to patients, some of who can be society’s most vulnerable. PlantEd Collective wants to change that.

Jade Proudman, Carly Barton, Liz Dyer, Abby Hughes and Victoria Logan share a passion for helping people understand holistic wellness practises, led by cannabis and it’s efficacies, using the very latest research from around the world.

Their goal with PlantEd Collective is to create engaging dialogue and provide accurate information to help educate people — starting with their December launch that includes Rikki Lake and Abby Epstein.

We spoke to them about breaking stigma, the re-education process and the power of the female.

Why do U.K. cannabis consumers need PlantEd Collective?

Liz Dyer: Each member of the PlantEd team brings very a different experience, from activism and education to yoga practitioners and boundary breakers. As cannabis consumers, we understand this space and most importantly, we understand the consumer needs and barriers to accessing cannabis information. Cannabinoid consumers in the U.K. are awash with information that is often misleading and fraught with challenges.

Jade Proudman: We see the real-world implications of this daily. There are barriers to CBD suppliers sharing information about medicinal benefits due to regulation. There are also legal barriers to discussing medicines containing THC. The information that makes it to U.K. consumers is often outdated and not practical. There is currently no safe, reliable place for consumers to digest the latest science, or educate themselves from a place of independence.

How will PlantEd Collective help break the information barrier between plant and people in the U.K.?

Carly Barton: Our not-for-profit scheme hopes to tackle this head-on. Many organizations are focused on educating policymakers and medical professionals in a top-down approach. We want to fill the gap in a ground-up approach, building knowledge within the consumer community so that choices are made from a place that is informed.

We aim to tackle this by providing access to digestible summaries of scientific developments, enlisting the engagement of high-profile researchers and developers to bring conversational content via accessible podcasts

We will design short courses to enable consumers to teach themselves and increase the knowledge base from the ground up and provide resources for families and children to instil high-quality education and dispel the tension that so often exists in a family when dealing with stigma.

How does PlantEd’s information differ from, say other sources like scientific journals?

LD: Much of the information out there is wrapped up in weighty, medicalized documents. We would like to think that you won’t need a medical degree or a library full of cannabis books to digest the information that we will be providing. We will be engaging with the community on what they would like to know more about and provide that service.

CB: That’s a big issue and efficacy and safety information is so often presented in very inefficient ways. Either the research is too complex to understand, or it comes from the recreational arena which is full of jargon and cultural terminology, for which you often need a translator to get your head around.

Let’s take consumption methods as an example. There are hundreds of studies done on vaporized cannabinoids, but there is nowhere that will break this down for patients. What are the risks and benefits of vaporizing over different consumption methods? Where do I go to get a vaporizer? How do I dose using one? What are the benefits of dry herb vaporizers? Do they cause lung issues? And what on earth is ‘dabbing’, RSO, FECO, AVB? Vera from three doors down would not know where to start!

JP: We feel that the combination of our collective education, experience and advocacy work means that we can disseminate, signpost and summarize these burning questions into practical steps meaning barriers to accessing the information are more easily broken.

Victoria Logan: We also recognize that our further specialisms in health and wellbeing — yoga, meditation and mindfulness practices — enhance our holistic approach.

What are some of the topics you plan to cover?

LD: We are currently developing a PlantEd curriculum with wide-ranging topics. We want to address the basics and give consumers a route to engaging with more advanced topics.

For example, a consumer may come to us for education on the endocannabinoid system and then perhaps take a short course in terpene therapeutics. For supporting consumers with anxiety issues, with Victoria’s expertise, we can offer support with breathwork and yoga sequences combined with information on plant-based approaches.

What are the most common misconceptions you hear about cannabis?

CB: All stigma comes from a place of conditioning following years of mass media hype that has systematically pushed down the benefits of cannabis and blown the risks out of all proportion. A lot of the stigma comes from a place of ‘all drugs are bad’ and there is seemingly no academic basis for this argument. It exists because that’s what people have been told to think.

Cannabis consumption in the U.K. is often associated with either anti-social behaviour or connections to the mental health risks, which when compared with readily available drugs like alcohol, caffeine and sugar, are extremely low.

LD: Funnily enough, the stigmas that exist around cannabis do vary from country to country; in Thailand, their argument has nothing to do with mental health, they are concerned that they would have lazy workers.

VL: We often hear that cannabis consumers are unproductive, yet we feel more productive now than we have ever been and that comes down to cannabis education.

CB: The most common question I am asked when speaking about the benefits of cannabis and my health is, ‘Aren’t you high all the time?’ which I find interesting, because I felt MUCH more inebriated when consuming opiates. The alternative for chronic pain patients is heroin-type drugs.

LD: And no one ever visits a hospital patient with some grapes and demands to know if they are high on their prescribed medication.

Why is it important that PlantEd Collective is the only entirely female-led collective in the U.K.?

VL: In Hatha yoga, we are taught to practice with balance in everything that we do, the breath, postures, the balancing of the Lunar energy: the female, with the Solar energy: the male. Everything in life needs balance.

The PlantEd Collective are the balance which is really needed currently in the cannabis world because cannabis culture has been a male-dominated space for many years. We have only just started to see real change in the U.K. following the emergence of female advocates. The law was only changed, after all, because mothers desperately petitioned to get access for their children.

CB: There is a change in the image here from cannabis being associated with ‘teenage boys on BMX bikes’ to ‘women advocating for wellness’ that brings about a different energy with which to step forward. Women are nurturers, mothers, friends, sisters. There are no aggression tactics, instead there is knowledge, support and unwavering determination to get stuff done.

When we talk about cannabis, we are talking about a female plant.

LD: Yes! So who better to advocate for its powerful qualities?

Abby Epstein and Ricki Lake will be at the PlantEd Collective launch in December. PHOTO | PlantEd Collective

Why join forces to create PlantEd?

Jade: Whilst we have been extremely fortunate in our respective fields to be given the opportunities to learn and grow, something really dynamic happens when we work together. Where one is lacking in knowledge or experience, another team member jumps in and fulfils that need. We have all been very aware of each other’s work for some time, however, it took us all accidentally coming together as a panel at Trewfields (a cancer festival) to really understand that our combined specialisms make up such a massive knowledge base.

VL: It was a particularly emotional and challenging panel that day where we found that we were able to not only answer every question that came up, but that we could utilize each other to create a conversation that brought about much more than off-the-cuff responses. Without any preparation or discussion, we provided real ‘spade-a-spade’ insight and were able to reference case studies and highlight specific research for patients who were in dire need of education and support.

LD: We are delighted to have already been booked for next year’s Trewfields Festival.

Liz, you’ve written two children’s books which the collective plans to release. Are you developing any other services aimed at families?

LD: Yes, there are more in the pipeline! This is something which is very close to our hearts and we have experienced, first-hand, many of the issues raised in the books. We know how difficult it can be to open a conversation about this with those we love, those with whom we work and sometimes even with ourselves. These books aim to bridge that gap. There will be supporting materials available alongside the books and we will open an online forum to aid discussion of these subjects. We will host family days and events to provide support for families and normalise the use of plant-based medicines.

The first book, ‘Only a Plant’, is an accessible text for all ages which explains how useful a cannabis plant is in general — from the perspective of the plant itself. The second book, ‘Mum’s Medicine,’ is narrated by a child whose mother has chosen to replace a plethora of prescribed medications with a plant-based approach. The books provide a starting point for engaging in dialogue and supporting education and understanding. These books are important because they mirror real-life situations currently affecting children and families who choose cannabis as medicine.

CB: These books are so desperately needed. Kids don’t have the same negative associations with the plant and when it’s explained appropriately, they instantly understand why it is so important. My nine-year-old nephew reviewed Liz’s two books and got a lot out of them. He then asked for a plant medicine book for his birthday, so he can find out more about other plants that help people. That is truly very special. It is important that as we enter a new paradigm in embracing natural treatment methods, that we build resources in to educate people from a young age.

How will the digital platform integrate health and wellness?

VL: We each utilize cannabinoids and other plant medicine alongside other wellness practices. We hope to do a series on companion herbs and their uses, including documenting our own supplementary regime for patients interested in exploring alternatives to pharmaceuticals. As a Hatha Yoga practitioner, I teach a range of techniques and am in the process of developing resources for companion practices that work synergistically with cannabinoids to realign the body’s energy and boost pathways to wellness and mindfulness.

You will soon release a podcast, can you reveal some of the guests you have lined up?

CB: We can’t say too much about our Podcast plans yet, as it is rather top secret! But we think it’s safe to say that we have some incredible people lined up for our series. We will be having a cup of tea and a chat to some of the world’s most high-profile researchers, scientists, authors, doctors, master growers and innovators.

Tell us about the PlantEd Collective launch event in London featuring Abby Epstein and Ricki Lake, makers of ‘Weed the People’.

JP: We are ecstatic to be welcoming Ricki Lake and Abby Epstein to the team for the night of our launch. These amazing women have witnessed the power of cannabis as medicine and produced a film that the world needed to see. We will be playing some clips of ‘Weed the People’ on the evening and having a fireside chat, all together, about the content and how it relates to the situation for consumers in the U.K. We will host an audience of patients, carers, doctors and industry leads to join us in a conversation about the route to access, education and the reduction of stigma, for the benefit of generations to come.

For more information, visit the PlantEd Collective website. For details on their launch party with Ricki Lake and Abby Epstein, visit eventbrite.co.uk.

Cannabis

Minnesota Opens $10.9 Million CanRenew Grant Round for Community Restoration

Minnesota’s next CanRenew round offers community restoration funding, with applications due December 15. The program does not finance cannabis business operations.

Published

on

Minneapolis skyline and a bridge over the Mississippi River

Minnesota has opened another round of CanRenew grants, putting community restoration alongside the business side of cannabis legalization. The Office of Cannabis Management announced the application window on October 22, with submissions due December 15, 2026, at 4:30 p.m. Central Standard Time. For local organizations, the opportunity is to propose a specific investment in communities affected by cannabis prohibition.

The state’s announcement describes a $10.9 million program and anticipated awards ranging from $50,000 to $2 million. OCM expects to select between 15 and 50 organizations. These are planning estimates for a competitive process, rather than commitments to particular applicants or neighborhoods.

A community grant with a defined purpose

CanRenew’s foundation is Minnesota Statutes section 342.70. The law directs funding toward organizations investing in communities where long-term residents qualify as social equity applicants. It describes community investment broadly, including economic development, health-related social conditions, violence prevention, youth development and civil legal aid.

That breadth matters. A cannabis-related public program can serve people who have no intention of opening a dispensary or cultivating a commercial crop. Its connection to legalization lies in the harms it is designed to address and the communities it serves, rather than a requirement to sell cannabis.

The statute also requires applicants to explain community need, expected benefits, costs and their ability to deliver results. Previous experience and community support are central considerations. Youth civic engagement, leadership and youth-led health education receive explicit priority, giving prospective applicants a clearer picture of the program’s public purpose.

Eligibility does not mean business funding

The current request for proposals includes nonprofits, educational institutions, federally recognized Tribes, local governments, private businesses and community groups among potential applicants. Unincorporated groups need an eligible fiscal sponsor. Registration, organizational capacity and the ability to administer the proposed work remain part of eligibility.

However, the applicant’s organizational form does not determine what the money can buy. The RFP excludes using grants to start, operate or expand a business, as well as revenue-generating entrepreneurial activity. A private company’s eligibility to propose community work should therefore not be read as permission to finance its own commercial expansion.

For anyone scanning the headline for startup capital, that distinction is the first useful check. Begin with the project’s purpose, who benefits and how it meets the restoration criteria, before investing time in a budget or assuming a cannabis license is the route into this funding.

Where the community connection comes in

OCM’s program guidance explains that an eligible community need not consist entirely of people individually verified as social equity applicants. The focus is the community served. Its mapping tool can help document several geographic indicators, while projects based on cannabis convictions or policing may need other supporting evidence.

The same guidance distinguishes expanding an eligible existing program from merely paying its current operating expenses. Applicants should identify what additional reach or benefit the proposed grant would create. A familiar program name alone does not explain how a new investment would repair prohibition-related harm in a specific community.

That is a useful lens for residents, too: look for a defined community benefit and an accountable organization, rather than treating the size of an announced grant pool as evidence that a particular local service has already received money.

Different programs serve different needs

The agency’s grants overview separates CanRenew from other Minnesota initiatives. CanGrow supports farmer assistance and loan-related work. Programs administered through the Department of Employment and Economic Development include CanStartUp, CanNavigate and CanTrain, addressing microbusiness lending, navigation assistance and workforce development respectively.

Those names are easy to confuse. Applicants should follow each program’s own current terms and opening dates; an open CanRenew round does not establish that every other initiative is accepting applications. Nor does appearing on the same overview make their eligibility requirements interchangeable.

What to check before applying

Applicants should also plan for administration after an award. The RFP requires a preaward risk assessment and a fully executed agreement before eligible spending begins. Receiving a selection notice does not, by itself, make earlier expenses reimbursable. That timing deserves attention when designing a project’s start date.

The published CanRenew timeline anticipates application review beginning in January 2027, with grant negotiations and project starts later in that year. The application window is therefore the beginning of a selection process, not an announcement that funds have already reached recipients.

Prospective applicants can use OCM’s current application materials to check the work plan, budget and required attachments, and consult the listed information sessions before the deadline. For Minnesota’s cannabis community, this round offers a concrete way to follow legalization beyond store openings: which organizations propose restoration work, which investments are selected and what results they ultimately deliver.

Illustrative stock view of Minneapolis; not a CanRenew-funded project. Photo: Kate L / Pexels.

Continue Reading

Cannabis

Khalifa Kush Plans a Halloween Debut in New York

Khalifa Kush plans to bring KK and Violet Sky flower and pre-rolls to New York on October 31 through a partnership with cultivator and distributor Skyworld.

Published

on

Dried cannabis flowers beside a glass jar

Khalifa Kush is planning a Halloween entrance into New York’s licensed cannabis market. Wiz Khalifa’s brand says sales are set to begin October 31 through a partnership with New York cultivator and distributor Skyworld. As of October 23, that date is still ahead: this is a preview of an announced launch, rather than a report that the products have already reached stores.

The company’s corrected October 14 announcement identifies two starting cultivars, KK and Violet Sky, in flower and pre-roll formats. It describes an initial rollout to 36 dispensaries: seven in New York City and another 29 across Upstate New York and Long Island. These are the brand’s announced distribution plans, not independently confirmed inventory at every location.

A local partner behind a familiar name

Skyworld will handle New York cultivation and distribution, according to the announcement. That makes the local operation central to what consumers eventually buy. A recognizable national brand name tells only part of the story; the cultivation partner, specific batch and store availability are the details shoppers can check when launch day arrives.

Skyworld’s own website describes the business as Indigenous-owned and New York-based, and lists cultivation, processing and distribution license numbers. It identifies SJR Horticulture, LLC as its operator. The company also provides a lab-results section, giving readers a place to look for product documentation rather than relying solely on launch publicity.

Those details establish how Skyworld presents its operation; they do not substitute for checking the state’s licensing resources or a particular product’s certificate. The announcement also corrected its partner’s name from “Skyworld Cannabis” to “Skyworld.” We use the corrected name here.

KK brings a longer backstory

On its KK product page, Khalifa Kush says the original cultivar was developed for Wiz Khalifa’s personal preferences in the early 2010s. The brand describes a period of private use before its first flower sales at Tryke’s Reef dispensaries in the southwestern United States in 2016. That is the company’s account of the cultivar’s commercial history.

It explains why this New York release carries a recognizable identity before any local customer opens a package. The name connects the artist’s cannabis persona with a product line that has moved through multiple state markets. It is also a reminder that a New York debut is a new distribution milestone for an established brand, rather than the creation of an entirely new cultivar.

The broader KK catalog includes formats beyond flower and pre-rolls. That does not mean all of them are included in the New York opening. The dated announcement is the appropriate guide to the initial local offering; later additions should be reported when the company or retailers confirm them.

Violet Sky adds a different genetic branch

The brand’s Violet Sky page describes a selection effort beginning in early 2021 and a cultivar emerging in late 2022. It identifies the cross as Khalifa Mints and GastroPop, and presents Violet Sky as the third addition to its lineup. Those are breeder and brand descriptions, not independent genetic testing by Cannabis Aficionado.

That distinction is especially useful with cultivar coverage. A lineage can help enthusiasts understand how a company positions a release, but it does not tell an individual reader exactly how a product will feel. We have not sampled these New York batches, and the announcement does not establish their final laboratory results, retail pricing or freshness at any particular shop.

Readers following New York’s plant pipeline can also see our coverage of the state’s upcoming nursery application window. Nursery licensing and a branded retail rollout are separate developments, but both make the people and businesses behind the genetics worth paying attention to.

What to check before making the trip

New York’s Office of Cannabis Management consumer guidance recommends checking the dispensary verification tool displayed at licensed storefronts. It also directs consumers to look for the state’s universal symbol on regulated products and a QR code or link to the batch’s certificate of analysis. The agency’s resources are intended for adults 21 and older.

For a planned launch, store-level confirmation is another practical step. Check a participating dispensary’s current menu or contact the store before traveling. An announced statewide rollout does not establish that both cultivars, every package size or every format will be available at the same time in every shop.

For now, the appeal is a clear date and a focused starting lineup: two cultivars, two formats and a named New York partner. The next reporting milestone is October 31 itself, when actual menus and batch information can show how the promised launch translates into a local shopping experience.

Illustrative stock cannabis photograph; not identified as KK, Violet Sky or Skyworld products. Photo: RDNE Stock project / Pexels.

Continue Reading

Cannabis

Section 781 Turns a Hemp Law Into a Cannabis Cultivar and Growers Challenge

Herbies and Blimburn have put a federal provision’s name on a new cannabis line, pairing three versions with a grow-diary competition.

Published

on

Rows of green cannabis plants inside a greenhouse

Cannabis names often borrow from food, music or geography. A new collaboration between Herbies Seeds and Blimburn Seeds takes a more bureaucratic route: Section 781. The line shares its name with a federal provision rewriting the definition of hemp, and its launch comes with a competition built around public grow diaries.

The announcement, published by Cannabis Business Times on October 23, was issued by the company on October 22. It describes three versions of the line and a challenge intended to follow participating plants from seed to harvest. This is a commercial launch with a political reference, rather than a new finding about how the genetics perform.

One name, three different records

The official project’s cultivar page lists Autoflower, Photoperiod and Fast Flowering entries. The records are not identical. They describe different growing timelines and different stated cannabinoid profiles, so a claim attached to one version should not automatically be applied to all three.

For example, the project lists 77–87 days from seed to harvest for the autoflowering version. Its photoperiod record instead lists a flowering period of 56–70 days. Those are different clocks: one begins at the seed stage, while the other describes a particular part of plant development. Putting the numbers beside each other without that distinction can make a comparison more confusing than useful.

The company’s announcement identifies OG Kush and Strawberry Diesel in the original version’s background. That is the breeder’s description of lineage. Cannabis Aficionado has not grown or independently tested these plants, and the announcement should not be read as our confirmation of a particular aroma, effect, yield or laboratory result.

For readers who follow genetics, the interesting part is the invitation to document variation. A diary can show what one grower observed in one setting. Several diaries may reveal a wider range of outcomes. Neither format automatically turns a branded launch into a controlled trial.

The competition is built around documentation

According to the challenge’s entry information, registration is open until December 30, 2026. Participants use the HarvestED platform to keep a diary, and only the Section 781 line is eligible. The published schedule gives different diary-completion dates for the three categories in spring 2027.

The project describes three principal categories, with three winners in each, plus a separate Best Looking Plant award. Its prize page identifies that additional award as limited to the United States and the photoperiod category. Prize availability and eligibility conditions deserve a direct reading; a promotional summary is not a substitute for the organizer’s current rules.

That matters because this is not simply a photo contest with an interchangeable plant in the frame. The challenge ties eligibility to a named commercial line and to records produced over time. Anyone considering it should distinguish the creative appeal of the project from its entry requirements and the laws applying where they live. This article does not establish anyone’s eligibility to purchase, cultivate or enter.

The posted completion schedule sets March 15, 2027 for Auto diaries, March 30 for Fast diaries and May 31 for Photoperiod diaries. Registration and diary completion are therefore separate deadlines. A reader following the project can watch whether entries document the full period promised, rather than judge the entire line from an attractive early photograph.

The distinction between observation and comparison is useful here. To evaluate two diaries, look for clearly identified versions, dates and conditions. A striking image alone does not tell a reader whether two plants were observed at comparable stages or whether their records answer the same question.

What the legal name actually refers to

Section 781 of Public Law 119-37 changes the statutory definition of hemp. Among its provisions is an exclusion concerning viable seeds from plants above a specified total-THC concentration, including THCA. The source plant is part of that wording, which makes the provision more specific than a general question about whether a seed itself contains much THC.

The statute’s name on a seed package does not certify that package’s legal status. Nor does a company’s reading of a provision resolve the separate questions of implementation, documentation, shipping or state law. The launch is best understood as a response to regulatory uncertainty, not a route around it.

That upstream focus also connects with New York’s new nursery licensing window, which addresses a different issue: how licensed businesses supply starting material inside a state-regulated market. Federal hemp definitions and state nursery permissions should not be treated as interchangeable authorizations.

A launch worth following through the diaries

Section 781 is an unusually literal example of cannabis branding absorbing the policy debate around the plant. The next useful evidence will be what the organizers publish, how the competition is administered and what the diaries actually document.

Until then, keep the categories separate: breeder claims, competition rules and legal requirements each answer a different question. The name may be memorable, but the records behind it will be more informative than the label alone.

Illustrative stock cultivation photograph; these plants are not identified as Section 781. Photo: CRYSTALWEED cannabis / Unsplash.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.